[go: up one dir, main page]

PH12016502047A1 - Niacinamide for including generation of antimicrobial peptides - Google Patents

Niacinamide for including generation of antimicrobial peptides

Info

Publication number
PH12016502047A1
PH12016502047A1 PH12016502047A PH12016502047A PH12016502047A1 PH 12016502047 A1 PH12016502047 A1 PH 12016502047A1 PH 12016502047 A PH12016502047 A PH 12016502047A PH 12016502047 A PH12016502047 A PH 12016502047A PH 12016502047 A1 PH12016502047 A1 PH 12016502047A1
Authority
PH
Philippines
Prior art keywords
niacinamide
antimicrobial peptides
including generation
skin
generation
Prior art date
Application number
PH12016502047A
Inventor
Majumdar Amitabha
Mathapathi Mruthyunjaya Swamy
Palanisamy Bharath
Sampath Kumar Ramya
Tiwari Jyoti Kumar
Original Assignee
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Nv filed Critical Unilever Nv
Publication of PH12016502047A1 publication Critical patent/PH12016502047A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Birds (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention relates to new use of niacinamide for triggering generation of AMPs (antimicrobial peptides) on skin. This has application in improving the immunity of skin, scalp and oral cavity against attack by microorganisms.
PH12016502047A 2014-05-12 2016-10-14 Niacinamide for including generation of antimicrobial peptides PH12016502047A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2014/059590 WO2015172801A1 (en) 2014-05-12 2014-05-12 Niacinamide for inducing generation of antimicrobial peptides

Publications (1)

Publication Number Publication Date
PH12016502047A1 true PH12016502047A1 (en) 2017-01-09

Family

ID=50771476

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12016502047A PH12016502047A1 (en) 2014-05-12 2016-10-14 Niacinamide for including generation of antimicrobial peptides

Country Status (8)

Country Link
JP (1) JP6446065B2 (en)
CN (2) CN113908074A (en)
BR (1) BR112016024400A2 (en)
EA (1) EA031758B1 (en)
MX (1) MX375738B (en)
PH (1) PH12016502047A1 (en)
WO (1) WO2015172801A1 (en)
ZA (1) ZA201607105B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10722436B2 (en) 2015-08-10 2020-07-28 Mary Kay Inc. Topical compositions
WO2017060211A1 (en) 2015-10-05 2017-04-13 Unilever N.V. A skin lightening composition
BR112018072388B1 (en) * 2016-05-10 2021-11-16 Unilever Ip Holdings B.V. TOPICAL COMPOSITION, NON-THERAPEUTIC METHOD OF DISINFECTION OF A SURFACE AND NON-THERAPEUTIC USES OF A COMPOSITION
CA3023369A1 (en) 2016-05-26 2017-11-30 Unilever Plc Antimicrobial compositions for topical use
EP3426276B1 (en) 2017-05-24 2024-01-24 Follea International Synephrine compositions
EP3703690A1 (en) * 2017-10-30 2020-09-09 Unilever N.V. Use of niacinamide for microbiome balancing
CN111491612B (en) * 2017-12-18 2023-10-20 联合利华知识产权控股有限公司 topical composition
WO2019121548A1 (en) 2017-12-18 2019-06-27 Unilever N.V. A topical composition based on niacinamide derivative
CA3093321A1 (en) 2018-03-13 2019-09-19 Unilever Plc A sanitizer composition
WO2022117404A1 (en) * 2020-12-03 2022-06-09 Unilever Ip Holdings B.V. Hydroxystearic acid for inducing generation of antimicrobial peptides
JP2025528241A (en) * 2022-08-25 2025-08-26 ユニリーバー・アイピー・ホールディングス・ベスローテン・ヴェンノーツハップ Virus inactivation or killing and compositions thereof
WO2024042554A1 (en) * 2022-08-25 2024-02-29 Istituto Fondazione Di Oncologia Molecolare Ets A pharmaceutical composition for treatment of viral infections

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN892496A0 (en) * 1996-03-25 1996-04-18 Technical Consultancy Services Pty Limited Acne treatment
US7026308B1 (en) * 1999-06-25 2006-04-11 The Procter & Gamble Company Topical anti-microbial compositions
AU2005293830B2 (en) * 2004-10-15 2010-10-21 Bayer Consumer Care Ag Acidic and buffered skin-care compositions comprising nicotinamid and an absorbing agent
CN101019865A (en) * 2007-01-23 2007-08-22 中国医学科学院皮肤病医院 Compound nicotinamide medicine for antiphlogosis, wet storage and eliminating spot
US20130052162A1 (en) * 2010-04-20 2013-02-28 Cedars-Sinai Medical Center Boosting immune defense by upregulating ccaat/enhancer binding protein epsilon
US20130217655A1 (en) * 2010-10-10 2013-08-22 Dermipsor Ltd. Compositions for treating psoriasis of the scalp
FR2973699B1 (en) * 2011-04-05 2013-04-26 Oreal NOVEL ACTIVE INGREDIENT TO STIMULATE THE PRODUCTION OF ANTI-MICROBIAL PEPTIDES IN SCALP, USEFUL IN PREVENTING AND / OR TREATING SCALPLET FILM CONDITIONS
US8293790B2 (en) * 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
DE102012002592A1 (en) * 2012-02-13 2013-08-14 Dr. Kurt Wolff Gmbh & Co. Kg Use of an agent for stimulating the gene expression of antimicrobial peptides (AMP)
ES2859758T3 (en) * 2012-06-15 2021-10-04 Conaris Res Institute Ag A pharmaceutical composition containing nicotinic acid and / or nicotinamide and / or tryptophan to positively influence the intestinal microbiota
EP2742942B1 (en) * 2012-12-14 2019-05-22 Unilever N.V. Niacinamide for inducing generation of antimicrobial peptides

Also Published As

Publication number Publication date
BR112016024400A2 (en) 2017-08-15
EA031758B1 (en) 2019-02-28
CN113908074A (en) 2022-01-11
JP2017515829A (en) 2017-06-15
JP6446065B2 (en) 2018-12-26
WO2015172801A1 (en) 2015-11-19
ZA201607105B (en) 2018-05-30
MX2016014760A (en) 2017-03-06
MX375738B (en) 2025-03-06
EA201692284A1 (en) 2017-03-31
CN106413680A (en) 2017-02-15

Similar Documents

Publication Publication Date Title
PH12016502047A1 (en) Niacinamide for including generation of antimicrobial peptides
ZA201708692B (en) Antibacterial compounds
CA163246S (en) Handle for toothbrush
AU2015296298A8 (en) Flagellin-based agents and uses including effective vaccination
EP4299122A3 (en) Compositions and methods for treating skin and mucous membrane diseases
MY193650A (en) Extracellular matrix compositions
MX2021010886A (en) Medicaments for slowing parkinson's disease.
PH12017500836A1 (en) Transdermal formulations
MX359181B (en) Collagen hydrolysate and use thereof.
MX2016009241A (en) Methods of reducing malodor and bacteria.
IN2014MU00455A (en)
MX2017012654A (en) Protoxin-ii variants and methods of use.
MX367393B (en) ANTIFUNGAL COMPOSITIONS FOR THE TREATMENT OF SKIN and NAILS.
SG10201900598TA (en) Factor viii formulation
MX368582B (en) Gardenia extract for colouring the skin.
MX2016015017A (en) Dentifrice compositions with improved fluoride stability.
PH12017501979A1 (en) Pharmaceutical compound
EP3162358A4 (en) Skin whitening composition containing chemokine
PH12018501166B1 (en) Concentrated gibberellin solution formulations
MX2016004961A (en) Methods and compositions for treatment of s. equi infection.
MX2015015850A (en) Flavor and fragrance compositions containing thiopyran-carbaldehy de.
PH12014000104A1 (en) Therapeutic methods and compositions for treating diabetes
UA99992U (en) 2,34-tetrahydropyridin-6-thiolate
UA92840U (en) Dehydration-dehreasignation solution for plastination of anatomical preparations
GR20150200058U (en) Spirulina-based cosmetic products